Menten AI
Menten AI designs peptide and protein therapeutics using generative AI, physics-based models, and quantum simulations to create peptide macrocycles for complex drug targets.
About Menten AI
Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.
Products
Module that analyzes target protein structures to pinpoint optimal binding sites, including previously unrecognized surfaces.
Generative AI platform for the de novo design of peptide macrocycles.
Physics-based generative AI engine that performs iterative, multi-parameter design cycles to optimize properties such as stability, affinity, and permeability.
Module that fine-tunes top hits through in silico amino acid substitutions to improve potency, stability, and permeability without experimental structural data.
Security and compliance
No security details published yet
Menten AI hasn't published certifications or security practices that we could find. Ask their team for audit reports.
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim Menten AI